Cargando…
Annuity payments can increase patient access to innovative cell and gene therapies under England’s net budget impact test
Background: Cell and gene therapies have the potential to provide therapeutic breakthroughs, but the high costs of researching, developing, manufacturing and delivering them translate into prices that may challenge healthcare budgets. Various measures exist that aim to address the affordability chal...
Autores principales: | Jørgensen, Jesper, Kefalas, Panos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Routledge
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5560408/ https://www.ncbi.nlm.nih.gov/pubmed/28839525 http://dx.doi.org/10.1080/20016689.2017.1355203 |
Ejemplares similares
-
The potential price and access implications of the cost-utility and budget impact methodologies applied by NICE in England and ICER in the US for a novel gene therapy in Parkinson’s disease
por: Jørgensen, Jesper, et al.
Publicado: (2018) -
The Eighth Annuity
Publicado: (1868) -
Pensions and Deferred Annuities
Publicado: (1877) -
Upgrading the SACT dataset and EBMT registry to enable outcomes-based reimbursement in oncology in England: a gap analysis and top-level cost estimate
por: Jørgensen, Jesper, et al.
Publicado: (2019) -
Life insurance, annuities & pensions
por: Pedoe, Arthur, et al.
Publicado: (1964)